EFG Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,175
Closed -$6.56M 208
2024
Q1
$6.56M Buy
20,175
+901
+5% +$221K 1.13% 12
2023
Q4
$3.67M Buy
19,274
+2,251
+13% +$425K 0.7% 46
2023
Q3
$3.39M Buy
17,023
+357
+2% +$84.4K 0.81% 40
2023
Q2
$4.76M Sell
16,666
-2,679
-14% -$744K 1.02% 28
2023
Q1
$4.19M Buy
19,345
+2,080
+12% +$405K 0.93% 39
2022
Q4
$3.58M Buy
17,265
+1,034
+6% +$261K 0.8% 39
2022
Q3
$4.51M Sell
16,231
-2,796
-15% -$711K 1.04% 31
2022
Q2
$3.64M Buy
19,027
+3,268
+21% +$577K 0.77% 41
2022
Q1
$3.27M Buy
+15,759
New +$2.6M 0.49% 60

Other funds holding SWAV

EFG Asset Management's SWAV Position: Q2 2024 in Review

EFG Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 20,175 shares — an estimated $6.56M sold.

EFG Asset Management first reported a position in SWAV in Q1 2022 and held it in 9 quarters. The position peaked at $6.56M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • EFG Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • EFG Asset Management sold 20,175 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $6.56M.
  • EFG Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • EFG Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $6.56M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on EFG Asset Management's 13F filing for Q2 2024, filed 25 Jul 2024.